Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Range Bar | Range Expansion | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | -13.24% | |
| Spinning Top | Other | -13.24% | |
| Calm After Storm | Range Contraction | -13.24% | |
| Upper Bollinger Band Walk | Strength | -13.24% | |
| Inside Day | Range Contraction | -13.24% | |
| Wide Bands | Range Expansion | -13.24% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 10% | about 22 hours ago |
| Down 2 ATRs | about 22 hours ago |
| Down 1 ATR | about 22 hours ago |
| Down 5% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.4 |
| 52 Week Low | 0.51 |
| Average Volume | 2,367,901 |
| 200-Day Moving Average | 1.19 |
| 50-Day Moving Average | 1.37 |
| 20-Day Moving Average | 1.30 |
| 10-Day Moving Average | 1.52 |
| Average True Range | 0.25 |
| RSI (14) | 66.89 |
| ADX | 31.2 |
| +DI | 40.24 |
| -DI | 14.16 |
| Chandelier Exit (Long, 3 ATRs) | 1.82 |
| Chandelier Exit (Short, 3 ATRs) | 1.76 |
| Upper Bollinger Bands | 2.06 |
| Lower Bollinger Band | 0.55 |
| Percent B (%b) | 0.89 |
| BandWidth | 116.35 |
| MACD Line | 0.17 |
| MACD Signal Line | 0.05 |
| MACD Histogram | 0.1266 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.71 | ||||
| Resistance 3 (R3) | 2.74 | 2.49 | 2.58 | ||
| Resistance 2 (R2) | 2.49 | 2.29 | 2.48 | 2.53 | |
| Resistance 1 (R1) | 2.20 | 2.16 | 2.08 | 2.17 | 2.48 |
| Pivot Point | 1.95 | 1.95 | 1.89 | 1.94 | 1.95 |
| Support 1 (S1) | 1.66 | 1.75 | 1.54 | 1.63 | 1.32 |
| Support 2 (S2) | 1.41 | 1.62 | 1.40 | 1.27 | |
| Support 3 (S3) | 1.12 | 1.41 | 1.23 | ||
| Support 4 (S4) | 1.09 |
